Article
Inhibitor of the nuclear transport protein XPO1 enhances the anticancer efficacy of KRAS…
medRxiv · 2022 · Husain Yar Khan
Key facts
| Title | Inhibitor of the nuclear transport protein XPO1 enhances the anticancer efficacy of KRAS G12C inhibitors in preclinical models of KRAS G12C mutant cancers |
|---|---|
| First author | Husain Yar Khan |
| Journal | medRxiv |
| Published | Jan 28, 2022 |
| DOI | 10.1101/2022.01.26.477874 |
| Devices mentioned | K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186, K854187 and 1 more |
| Product codes mentioned | JJH |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1